Printer Friendly and PDF

MASAC Issues Updated Treatment Document

July 1, 2013

The National Hemophilia Foundation’s (NHF) Medical and Scientific Advisory Council (MASAC) has issued the following updated document, which was adopted by NHF’s Board of Directors on June 13, 2013:

MASAC Document #217: MASAC Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorders (Revised April 2013)

The document includes:

  • Recommendations for physicians treating patients with hemophilia A and B, von Willebrand disease and other congenital bleeding disorders
  • Recommendations to manufacturers of coagulation products
  • Recommendations to the Food and Drug Administration

To view this document, click the link above or review the complete list of current MASAC documents. To request a hard copy of any current documents, please contact HANDI, NHF’s information resource center: or 1.800.424.2634